Product logins

Find logins to all Clarivate products below.


Clarivate Epidemiology’s coverage of influenza comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report diagnosed influenza event rates for each country, as well as annualized events projected to the national population.

All patient populations are forecast over a period of 10 years.

Clarivate Epidemiology’s influenza forecast will answer the following question:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of influenza over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology provides 10 years of forecast data for the following influenza patient population:

  • Diagnosed influenza event rates.

Note: Coverage may vary by country.

Related Market Assessment Reports

Report
Gene Therapy – Landscape & Forecast – Disease Landscape & Forecast (G7)
Approximately 80% of rare diseases have a genetic etiology. Gene therapies have the potential to transform the treatment of rare diseases and, in some cases, provide a functional cure. The pipeline…
Report
Gout – Current Treatment – Treatment Algorithms: Claims Data Analysis – Gout (US)
Gout, a form of inflammatory arthritis, arises due to the persistent elevation of serum uric acid (sUA) levels. The condition manifests through sudden and intense gout flares, causing significant…
Report
Dry Eye – Landscape & Forecast – Disease Landscape & Forecast (G7)
Dry eye disease (DED) is characterized by the loss of tear film homeostasis, caused by the inadequate production or the rapid evaporation of tears. The DED market is evolving rapidly, driven by…
Report
Epilepsy – Landscape & Forecast – Disease Landscape & Forecast (G7)
Epilepsy is a complex neurological disorder marked by recurrent seizures, affecting approximately 4.7 million people across the major markets, as reported by Clarivate Epidemiology. Given epilepsy…
Report
Asthma – Landscape & Forecast – Disease Landscape & Forecast (G7)
The asthma therapy market consists of many well-established drugs, including inhaled agents (e.g., GlaxoSmithKline’s Advair / Seretide, AstraZeneca’s Symbicort, Boehringer Ingelheim’s Spiriva…